Enhabit (EHAB) to Release Quarterly Earnings on Wednesday

Enhabit (NYSE:EHAB) is set to announce its earnings results after the market closes on Wednesday, May 8th. Analysts expect the company to announce earnings of $0.05 per share for the quarter. Enhabit has set its FY 2024 guidance at 0.120-0.430 EPS.Investors interested in listening to the company’s conference call can do so using this link.

Enhabit (NYSE:EHAB) last released its quarterly earnings results on Wednesday, March 6th. The company reported $0.03 EPS for the quarter, topping analysts’ consensus estimates of $0.02 by $0.01. Enhabit had a negative net margin of 7.69% and a positive return on equity of 1.55%. The company had revenue of $260.60 million for the quarter, compared to the consensus estimate of $260.30 million. During the same period in the previous year, the firm earned $0.32 EPS. On average, analysts expect Enhabit to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Enhabit Price Performance

Shares of NYSE:EHAB opened at $10.18 on Monday. Enhabit has a 12 month low of $7.12 and a 12 month high of $14.59. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.53 and a quick ratio of 1.53. The stock’s 50 day moving average price is $10.36 and its 200 day moving average price is $10.00. The stock has a market cap of $510.63 million, a price-to-earnings ratio of -6.28, a PEG ratio of 1.56 and a beta of 1.98.

Analyst Ratings Changes

EHAB has been the topic of several research reports. Jefferies Financial Group dropped their price target on shares of Enhabit from $15.00 to $14.00 and set a “buy” rating on the stock in a research report on Wednesday, March 6th. UBS Group upgraded Enhabit from a “sell” rating to a “neutral” rating and set a $9.50 target price on the stock in a report on Thursday, March 7th. Finally, Oppenheimer reiterated a “market perform” rating on shares of Enhabit in a research report on Thursday, March 7th. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $12.08.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.